Quest PharmaTech Inc.
$0.03+0.00%(+$0.00)
TickerSpark Score
63/100
100
Valuation
20
Profitability
60
Growth
36
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QPTFF research report →
52-Week Range64% of range
Low $0.01
Current $0.03
High $0.04
Companywww.questpharmatech.com
Quest PharmaTech Inc. , a pharmaceutical company, develops antibody based immunotherapeutic products for cancer. Its lead product candidate is Mab AR 9.
- CEO
- Ragupathy Madiyalakan
- IPO
- 2018
- Employees
- 3
- HQ
- Edmonton, AB, CA
Price Chart
+128.57% · this period
Valuation
- Market Cap
- $5.14M
- P/E
- -19.84
- P/S
- 0.00
- P/B
- 0.31
- EV/EBITDA
- -7.60
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -1.73%
- ROIC
- -2.82%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-1,801,000 · 40.32%
- EPS
- $-0.01 · 40.45%
- Op Income
- $-817,000
- FCF YoY
- -49.49%
Performance & Tape
- 52W High
- $0.04
- 52W Low
- $0.01
- 50D MA
- $0.03
- 200D MA
- $0.02
- Beta
- -0.25
- Avg Volume
- 2
Get TickerSpark's AI analysis on QPTFF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our QPTFF Coverage
We haven't published any research on QPTFF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate QPTFF Report →